HomeOlmesartan Medoxomil HydrochlorothiazideOlmesartan Medoxomil Hydrochlorothiazide + Aliskiren

Does Olmesartan Medoxomil Hydrochlorothiazide Interact with Aliskiren?

Olmesartan Medoxomil Hydrochlorothiazide and Aliskiren have a contraindicated drug interaction according to U.S. FDA drug labeling data. Do not co-administer aliskiren with BENICAR HCT in patients with diabetes. Avoid use in patients with renal impairment (GFR <60 ml/min) due to increased risks of hypotension, hyperkalemia, and renal failure. The mechanism involves dual ras inhibition leads to excessive suppression of the renin-angiotensin system. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Olmesartan Medoxomil Hydrochlorothiazide Class
Thiazide Diuretic
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Olmesartan Medoxomil Hydrochlorothiazide and Aliskiren occurs because dual ras inhibition leads to excessive suppression of the renin-angiotensin system. Clinically, this means do not co-administer aliskiren with benicar hct in patients with diabetes. avoid use in patients with renal impairment (gfr <60 ml/min) due to increased risks of hypotension, hyperkalemia, and renal failure. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Olmesartan Medoxomil Hydrochlorothiazide and your doctor is considering prescribing Aliskiren (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Olmesartan Medoxomil Hydrochlorothiazide(Benicar Hct)+💊 Aliskiren(Tekturna HCT)

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Thiazide Diuretic
Drug B class
Source
NLP:olmesartan medoxomil-hydrochlorothiazide

What this means in plain English

Do not co-administer aliskiren with BENICAR HCT in patients with diabetes. Avoid use in patients with renal impairment (GFR <60 ml/min) due to increased risks of hypotension, hyperkalemia, and renal failure.

About Olmesartan Medoxomil Hydrochlorothiazide and Aliskiren

Olmesartan Medoxomil Hydrochlorothiazide is a Thiazide Diuretic. You may recognize them by the brand names Benicar Hct and Tekturna HCT. Both medications are taken by mouth. Both Olmesartan Medoxomil Hydrochlorothiazide and Aliskiren carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Dual RAS inhibition leads to excessive suppression of the renin-angiotensin system"

📖 Source: NLP:olmesartan medoxomil-hydrochlorothiazide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Olmesartan Medoxomil Hydrochlorothiazide and Aliskiren against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.